| Date | Title | Description |
| 02.05.2024 | Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device | Cell Factory Box
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable
RALEIGH, N.C., May 2, 2024 /PRNewswire-PRWeb/ -- ProPharma, the leading global provider of regulatory, clinical... |
| 04.10.2023 | ProPharma Introduces ClinCHAT, a Solution to Unleash the Power of Real-World Evidence with Conversational AI | ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners introduced ClinCHAT, a co-developed AI-powered c... |
| 02.08.2023 | ProPharma Announces the Appointment of Helen Hall as Global Head of Clinical Data Sciences | “I am eager to partner with ProPharma’s global team to ensure superior clinical data science solutions are delivered to our valued client partners, further enhancing our position as the global leader in the life sciences sector.”
RALEIGH, N... |
| 20.07.2023 | Dr. Laura Salazar-Fontana, Former FDA CMC and Immunogenicity Reviewer, Joins NDA Partners as Expert Consultant | NDA Partners is a ProPharma company. Dr. Salazar-Fontana’s extensive industry and regulatory experience in the development and regulation of biotherapeutic drugs will be valuable to clients developing biotherapeutics such as recombinant enz... |
| 28.06.2023 | Innovating Oncology Trials: Breaking Access Barriers, Optimizing Protocols and Navigating Regulatory Challenges, Upcoming Webinar Hosted by Xtalks | These topics have become increasingly important as the continued development of precision medicines has led to smaller study populations associated with higher uncertainty on the evidence-base for approval and reimbursement decision-making.... |
| 31.05.2023 | ProPharma Announces New Office in Medicon Village – Lund, Sweden | "Our new location will not only benefit our team, but also enable us to better serve our clients and provide them with the personalized services they need to succeed.” -Jason DeGoes, President of ProPharma
RALEIGH, N.C. (PRWEB) May 31,... |
| 17.05.2023 | ProPharma Announces the Appointment of Dr. Ronald Freeze, Ph.D., as Global Head of Medical Technology | "I am truly honored to have been given the opportunity to lead ProPharma's MedTech team. I am excited to drive innovative solutions for our clients and leverage my experience to further solidify ProPharma's position as the world's larg... |
| 09.05.2023 | Drug and Device Development Outsourcing with the Research Consulting Organization (RCO) Model, Upcoming Webinar Hosted by Xtalks | The RCO is a new service partner that has emerged in response to the shifting landscape of drug and device development outsourcing.
TORONTO (PRWEB) May 09, 2023
In this webinar, the featured speakers will showcase the success of ProPharma’s... |
| 09.05.2023 | ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics | "This collaboration represents a new era of drug development, where real-world data and advanced analytics play a crucial role in guiding research and development efforts," said Ariel Katz, CEO of H1.
RALEIGH, N.C. (PRWEB) May 09,... |
| 03.04.2023 | Navigating Regulatory Submissions with Science-Backed Strategies, Upcoming Webinar Hosted by Xtalks | Worldwide, regulators find that submissions that correctly and easily describe the science behind a product are easier to read and agree with.
TORONTO (PRWEB) April 03, 2023
The regulations governing drugs are built on the science employed ... |
| 03.04.2023 | ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent | “The growth in downtown Raleigh over the past few years has been monumental, and we’re excited to add another dimension to the city’s expanding commerce and life sciences scene. We are also proud to be the first ever Research Consulting Org... |
| 22.03.2023 | NDA Partners Appoints Alexander Vinks, PhD, PharmD, FCP, Prominent Clinical Pharmacologist, as Partner in the Firm | Dr. Vinks is a prominent pediatric and adult clinical pharmacologist with experience in population PK/PD and model-informed precision dosing. His leadership as Partner will further expand the services and support we provide to companies dev... |
| 01.03.2023 | ProPharma Announces the Appointment of Karl Deonanan as Chief Financial Officer to Support Next Phase of Growth | "We are thrilled to announce the appointment of Karl as our new Chief Financial Officer at ProPharma," said Michael Stomberg, CEO of ProPharma.
RALEIGH, N.C. (PRWEB) March 01, 2023
ProPharma Group (ProPharma), the leading global p... |
| 25.01.2023 | ProPharma Announces Acquisition Of UK-Based Digital Lab Consulting To Expand R&D Capabilities And Accelerate Product Development | RALEIGH, N.C. (PRWEB) January 25, 2023
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the life sciences industry, announces the acquisition of Digital Lab Consulting (DLC) – a globa... |
| 09.01.2023 | ProPharma Group Launches Revolutionary New Operating Model To Deliver Life-Saving Drugs, Medical Devices And Diagnostics To Market Faster | RALEIGH, N.C. (PRWEB) January 09, 2023
ProPharma Group – the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries – today launched the Research Consu... |
| 18.10.2022 | Diagnostic Device Executive Joins NDA Partners as Expert Consultant | Mr. Clark brings significant experience to our firm in the development and commercialization of diagnostics devices.
WASHINGTON (PRWEB) October 18, 2022
NDA Partners’ General Manager, Eric Fish, announced today that Kevin Clark, a diagnosti... |
| 05.10.2022 | Medical Device and Diagnostic Reimbursements Expert Joins NDA Partners as Expert Consultant | Ms. Gendrolis’ expertise provides a valuable addition to the services that we provide to companies developing reimbursement strategy as part of early-stage development planning.
WASHINGTON (PRWEB) October 05, 2022
NDA Partners’ General Mana... |
| 13.09.2022 | ProPharma Group announces the appointment of Bryan Katz as new Chief Strategy Officer (CSO) / Head of Corporate Development | ProPharma Group "Bryan’s extensive knowledge and technical expertise within the life sciences industry will provide an invaluable advantage as we explore strategic opportunities at all levels of the organization."Michael StombergP... |
| 13.09.2022 | Highly Regarded Cell and Gene Therapy Expert, Dr. Michael Mendicino, Joins NDA Partners as Expert Consultant | Dr. Mendicino’s extensive experience in CMC regulatory, regulatory strategy, development strategy, and diligence make him a valuable resource to our clients developing cell and gene therapies, gene editing, regenerative medicine, tissue eng... |
| 01.09.2022 | ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing Company | “We are thrilled to welcome Kateric to our high-performing portfolio of medical writing services,” said Michael Stomberg, CEO of ProPharma Group,"
CHICAGO (PRWEB) September 01, 2022
Since 2004, Kateric has established a reputation as a... |
| 23.08.2022 | ProPharma Group Acquires OneSource Regulatory to Bolster its Regulatory Consultancy Services | ProPharma Group “The partnership with OneSource Regulatory is a critical step in reinforcing ProPharma Group as a worldwide leader in providing end-to-end solutions to the pharmaceutical, biotech, medical device, and diagnostic industries,”... |
| 08.06.2022 | Quality and Regulatory Compliance Expert Joins NDA Partners | Ms. Hiebert’s quality and regulatory compliance experience will be valuable to medical device companies developing quality management systems to be compliant with ISO standards and EU MDD/MDR requirements.
WASHINGTON (PRWEB) June 08, 2022
N... |
| 11.05.2022 | Board Certified Vascular Surgeon Joins NDA Partners as Expert Consultant | Dr. Mackrell’s extensive clinical experience will be valuable to our clients developing and evaluating medical device products used to treat cardiovascular diseases and promote wound healing.
WASHINGTON (PRWEB) May 11, 2022
NDA Partners Gen... |
| 04.05.2022 | Former City of Hope Endowed Chair, Department of Pediatrics Joins NDA Partners as Expert Consultant | Dr. Rosenthal’s extensive clinical and research experience in the field of pediatric hematopoietic stem cell transplantation will be valuable to our clients developing therapies for pediatric patients.
WASHINGTON (PRWEB) May 04, 2022
NDA Pa... |
| 13.04.2022 | Former FDA CDRH Director, Office of Compliance, Joins NDA Partners as Expert Consultant | Mr. Silverman’s experience serving in leadership roles at FDA and in the medical product industry will be valuable to clients and law firms in matters related to regulatory, policy, and compliance issues.
WASHINGTON (PRWEB) April 13, 2022
N... |
| 16.03.2022 | ProPharma Group Announces the Acquisition of M Squared Associates | “This acquisition is a pivotal move that will positively impact our combined client base to provide full end-to-end support for getting medical devices, combination products and diagnostics to market,” said Michael Stomberg, CEO of ProPharm... |
| 08.02.2022 | Former FDA Medical Officer, Office of Orthopedic Devices, CDRH, Joins NDA Partners as Expert Consultant | Dr. Weber’s clinical and regulatory expertise will be beneficial to our clients developing therapies and products for orthopedic patients.
ROCHELLE, Va. (PRWEB) February 08, 2022
NDA Partners Vice President of Operations, Eric Fish, announc... |
| 05.01.2022 | Former Vice President, Quality Assurance, Tempus Labs Joins NDA Partners as Expert Consultant | Dr. Samra’s extensive experience in quality assurance and regulatory compliance will be valuable to our clients in the medical device, diagnostic, clinical lab, and software product areas.
ROCHELLE, Va. (PRWEB) January 05, 2022
NDA Partners... |
| 16.12.2021 | Former Amgen Executive Director of Research Quality and Compliance Joins NDA Partners as Expert Consultant | Dr. Baughman’s knowledge and extensive experience in preclinical and clinical PK/PD, bioanalysis, and ADME of both small and large molecules will further strengthen NDA Partners’ clinical pharmacology and pharmacometrics expertise to suppor... |
| 18.11.2021 | Highly Regarded Aerobiologist, Chad Roy, MSPH, PhD, Joins NDA Partners as Expert Consultant | Dr. Roy’s expertise in respiratory health and airborne infectious diseases with an emphasis on product development for highly infectious agents will be valuable to our clients developing therapies and vaccines for communicable airborne dise... |
| 06.10.2021 | ProPharma Group Announces the Acquisition of Pharmica Consulting | “This is a powerful combination of two highly complementary businesses,” said Michael Stomberg, CEO of ProPharma Group. “We are confident this acquisition will come as a value-added partnership to our combined client base."
OVERLAND PA... |
| 02.09.2021 | ProPharma Group and The Planet Group Announce Executive Leadership Changes and Branding of Combined Company | “We look forward to the next phase of growth as we continue on our mission and higher purpose to improve patient health and safety, said Michael Stomberg, ProPharma Group’s CEO.
OVERLAND PARK, Kan. (PRWEB) September 02, 2021
ProPharma Group... |
| 10.08.2021 | ProPharma Group Announces the Acquisition of iSafety Systems | “This acquisition continues to strengthen ProPharma Group’s position as the leading global provider of regulatory and compliance consulting, clinical research, pharmacovigilance, and medical information services," said Dawn Sherman, Pr... |
| 27.05.2021 | ProPharma Group and The Planet Group Announce Agreement to Merge | The complementary nature of this merger creates a dynamic platform with a truly global footprint and a complete line of service offerings to meet all of our clients’ needs. We are looking forward to the next phase of growth and our continue... |
| 28.01.2019 | The Weinberg Group Acquired By Propharma Group | ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and compliance services to the pharmaceutical... |
| - | PTC Presents Results from a Real-World Study of Steroid Switching in the Treatment of Patients with Dystrophinopathies | SOUTH PLAINFIELD, N.J., March 15, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced results from a real-world study of patients with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) who switched... |
